Cargando…

Real‐life use of oral disease‐modifying treatments in Austria

OBJECTIVES: To compare the efficacy, frequencies and reasons for treatment interruption of fingolimod, dimethyl fumarate (DMF) or teriflunomide in a nationwide observational cohort using prospectively collected data. MATERIALS AND METHODS: Two cohorts of patients with relapsing‐remitting multiple sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guger, Michael, Enzinger, Christian, Leutmezer, Fritz, Kraus, Jörg, Kalcher, Stefan, Kvas, Erich, Berger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767158/ https://www.ncbi.nlm.nih.gov/pubmed/30958901 http://dx.doi.org/10.1111/ane.13097

Ejemplares similares

Oral therapies for treatment of relapsing–remitting multiple sclerosis in Austria: a 2-year comparison using an inverse probability weighting method
por: Guger, Michael, et al.
Publicado: (2020)

Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing–remitting multiple sclerosis in Austria
por: Guger, Michael, et al.
Publicado: (2023)

Long-term outcome and predictors of long-term disease activity in natalizumab-treated patients with multiple sclerosis: real life data from the Austrian MS Treatment Registry
por: Guger, Michael, et al.
Publicado: (2021)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Non‐interventional, prospective, observational study on spasticity‐associated symptom control with nabiximols as add‐on therapy in patients with multiple sclerosis spasticity in Austria
por: Guger, Michael, et al.
Publicado: (2023)

Health Literacy and Health Care Utilization in Austria
por: Kvas, Andreas, et al.
Publicado: (2023)

Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry
por: Guger, Michael, et al.
Publicado: (2020)

Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS study in Austria
por: Guger, Michael, et al.
Publicado: (2022)

Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial
por: Altmann, Patrick, et al.
Publicado: (2022)

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
por: Bsteh, Gabriel, et al.
Publicado: (2021)

Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People
por: Aboul-Enein, Fahmy, et al.
Publicado: (2013)

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2022)

Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Impact of vaccination on COVID‐19 outcome in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Spontaneous spinal cord infarction in Austria: a two-center comparative study
por: Pikija, Slaven, et al.
Publicado: (2022)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
por: Dejaco, Christian, et al.
Publicado: (2022)

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
por: Ressler, Julia Maria, et al.
Publicado: (2021)

Bright light therapy as a non-pharmacological treatment option for multiple sclerosis-related fatigue: A randomized sham-controlled trial
por: Voggenberger, Lisa, et al.
Publicado: (2022)

Has the pandemic changed treatment strategy in multiple sclerosis?
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
por: Schurz, Natascha, et al.
Publicado: (2021)

Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
por: Monschein, Tobias, et al.
Publicado: (2020)

Quality of life during the COVID-19 pandemic in Austria
por: Dale, Rachel, et al.
Publicado: (2022)

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany
Publicado: (2021)

Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

A citizen science supported study on seasonal diversity and monoflorality of pollen collected by honey bees in Austria
por: Brodschneider, Robert, et al.
Publicado: (2019)

The Impact of Dental Pain on the Oral Health-Related Quality of Life (OHRQoL) of Preschool Children in Austria
por: Lembacher, Sophie, et al.
Publicado: (2023)

Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria
por: Gattringer, Thomas, et al.
Publicado: (2021)

Austria
por: Weber, Germain
Publicado: (2008)

Austria
Publicado: (1896)

Changing direction: the struggle of regulating assisted reproductive technology in Austria()
por: Griessler, Erich, et al.
Publicado: (2017)

Dermatitis linearis outbreak associated with Paederus balcanicus in Austria
por: Bakran-Lebl, Karin, et al.
Publicado: (2022)

Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project
por: Horner, Andreas, et al.
Publicado: (2020)

Economic burden of osteoporotic fractures in Austria
por: Dimai, Hans Peter, et al.
Publicado: (2012)

Simulated patients in medical education – a survey on the current status in Germany, Austria and Switzerland
por: Sommer, Michael, et al.
Publicado: (2019)

Visit of Thomas Stelzer, Governor of Upper Austria, Austria
por: Ordan, Julien
Publicado: (2019)

No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort
por: König, Theresa, et al.
Publicado: (2023)

Functional status and life satisfaction of patients with stable angina pectoris in Austria
por: Spinka, Fabian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tdde3po40opcm5etsgc8i7q616